II. Definitions
- Push Dose Intravenous Antibiotics
- Antibiotics that may be bolused intravenously (without infusion)
III. Advantages
- Rapid delivery of medication
- No need for additional preparation into a bag
- Does not monopolize the intravenous line
IV. Precautions
- Do not dilute formulations beyond their prepared concentration prior to bolus dosing
- Avoid bolusing high osmolality agents (>900 mOsm/kg)
- Do not replace continuous infusions in critically ill, Immunocompromised or patients with infections with borderline MIC
V. Preparations: Intravenous Bolus (FDA approved for bolus unless otherwise noted)
-
Penicillins
- Ampicillin or Ampicillin/Sulbactam (Unasyn)
- Oxacillin or Nafcillin
- Piperacillin/Tazobactam (Zosyn, not FDA approved for bolus)
-
Cephalosporins
- Cefazolin
- Cefotaxime
- Cefotetan
- Cefoxitin
- Cefuroxime
- Ceftazidime
- Cefepime (not FDA approved for bolus)
- Ceftriaxone (not FDA approved for bolus)
- Carbapenems
- Monobactams
- Aminoglycosides (not FDA approved for bolus)
VI. Preparations: Intramuscular
VII. References
- Hayes and Swaminathan in Herbert (2021) EM:Rap 21(4): 8-9